News European Approval of PTC Therapeutics Drug in Jeopardy Shares of PTC Therapeutics took a hit in premarket trading after the company revealed that European approval for its key Duchenne muscular dystrophy ... By fxcoach15th September 20230
News Outlook Therapeutics Inc. Stock Plummeted 71% Following FDA’s Control Response Letter Introduction The Control Response Letter The FDA issues a CRL when it determines that a drug cannot be approved in its current form ... By fxcoach30th August 20230